The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHIEVE LIFE SCIENCES INC | COMM | 004468500 | 11,149,303 | 2,453,092 | SH | DFND | 1 | 2,235,247 | 217,845 | 0 | |
AKERO THERAPEUTICS INC | COMM | 00973Y108 | 8,279,016 | 327,752 | SH | DFND | 1 | 115,275 | 212,477 | 0 | |
APPLIED THERAPEUTICS INC | COMM | 03828A101 | 41,560,961 | 6,111,906 | SH | DFND | 1 | 3,294,401 | 2,817,505 | 0 | |
ARDELYX INC | COMM | 039697107 | 4,337,470 | 594,174 | SH | DFND | 1 | 244,174 | 350,000 | 0 | |
ATHIRA PHARMA INC | COMM | 04746L104 | 4,090,250 | 1,492,792 | SH | DFND | 1 | 0 | 1,492,792 | 0 | |
AVIDITY BIOSCIENCES INC | COMM | 05370A108 | 4,555,320 | 178,500 | SH | DFND | 1 | 53,500 | 125,000 | 0 | |
CHINOOK THERAPEUTICS INC CVR | COMM | 169CVR016 | 30,949 | 79,357 | SH | DFND | 1 | 54,357 | 25,000 | 0 | |
CYBIN INC | COMM | 23256X100 | 351,475 | 850,000 | SH | DFND | 1 | 350,000 | 500,000 | 0 | |
DAY ONE BIOPHARMACEUTICALS I | COMM | 23954D109 | 4,471,369 | 270,664 | SH | DFND | 1 | 95,646 | 175,018 | 0 | |
EIGER BIOPHARMACEUTICALS INC | COMM | 28249U204 | 731,905 | 146,381 | SH | DFND | 1 | 56,381 | 90,000 | 0 | |
FIDELITY INV MMTRSY 1 680 | COMM | X9USDFIDT | 211,541 | 211,541 | SH | DFND | 1 | 0 | 211,541 | 0 | |
FULCRUM THERAPEUTICS INC | COMM | 359616109 | 7,080,000 | 750,000 | SH | DFND | 1 | 285,000 | 465,000 | 0 | |
ISHARES IBOXX INVESTMENT | COMM | 464287242 | 485,348 | 4,456 | SH | DFND | 1 | 0 | 4,456 | 0 | |
ISHARES MBS ETF | COMM | 464288588 | 2,070,208 | 22,400 | SH | DFND | 1 | 0 | 22,400 | 0 | |
KAYNE ANDERSON ENERGY INF | COMM | 486606106 | 1,471,800 | 147,033 | SH | DFND | 1 | 0 | 147,033 | 0 | |
KURA ONCOLOGY INC | COMM | 50127T109 | 2,772,900 | 130,000 | SH | DFND | 1 | 50,000 | 80,000 | 0 | |
KYMERA THERAPEUTICS INC | COMM | 501575104 | 2,265,632 | 56,359 | SH | DFND | 1 | 25,844 | 30,515 | 0 | |
MADRIGAL PHARMACEUTICALS INC | COMM | 558868105 | 11,491,265 | 43,032 | SH | DFND | 1 | 19,738 | 23,294 | 0 | |
MARINUS PHARMACEUTICALS INC | COMM | 56854Q200 | 1,628,104 | 180,100 | SH | DFND | 1 | 30,100 | 150,000 | 0 | |
MIRUM PHARMACEUTICALS INC | COMM | 604749101 | 1,758,400 | 70,000 | SH | DFND | 1 | 0 | 70,000 | 0 | |
PHATHOM PHARMACEUTICALS INC | COMM | 71722W107 | 9,238,625 | 869,927 | SH | DFND | 1 | 347,992 | 521,935 | 0 | |
PLAINS GP HOLDINGS LP-CL | COMM | 82889N632 | 25,045,570 | 1,372,360 | SH | DFND | 1 | 0 | 1,372,360 | 0 | |
SIMPLIFY ENHANCED INCOME | COMM | 82889N632 | 2,933,392 | 120,221 | SH | DFND | 1 | 0 | 120,221 | 0 | |
SUTRO BIOPHARMA INC | COMM | 869367102 | 1,101,750 | 195,000 | SH | DFND | 1 | 75,000 | 120,000 | 0 | |
SYNDAX PHARMACEUTICALS INC | COMM | 87164F105 | 1,981,564 | 83,259 | SH | DFND | 1 | 33,259 | 50,000 | 0 | |
TELESAT CORP | COMM | 879512309 | 2,500,717 | 290,781 | SH | DFND | 1 | 0 | 290,781 | 0 | |
TREVI THERAPEUTICS INC | COMM | 89532M101 | 897,000 | 260,000 | SH | DFND | 1 | 60,000 | 200,000 | 0 | |
TSCAN THERAPEUTICS INC | COMM | 89854M101 | 16,571,884 | 2,087,139 | SH | DFND | 1 | 1,040,223 | 1,046,916 | 0 | |
X4 PHARMACEUTICALS INC | COMM | 98420X103 | 743,650 | 535,000 | SH | DFND | 1 | 135,000 | 400,000 | 0 |